MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Neuropsychological and clinical assessment for the differential diagnosis of patients with PDD vs. DLB

    E. Fiorenzato, L. Weis, V. Camparini, F. Pistonesi, R. Schifano, E. Gasparoli, A. Antonini, R. Biundo (Venice, Italy)

    Objective: To explore the role of clinical neuropsychological tools in Parkinson’s disease-dementia (PDD) vs. dementia with Lewy bodies (DLB). First, to define the feasibility of…
  • 2018 International Congress

    Neuropsychological Assessment of Cognitive Dysfunction in Parkinson’s Disease: A Comparison of Four Screening Instruments

    S. Schnitzler, L. Flitsch, S. Kaesberg, J. Kessler, E. Kalbe, M. Barbe (Cologne, Germany)

    Objective: To compare four different neuropsychological screening instruments (DemTect, Mattis Dementia Rating Scale (MDRS), Mini Mental State Examination (MMSE) and Parkinson Neuropsychometric Dementia Assessment (PANDA))…
  • 2018 International Congress

    Neurocognitive outcomes of STN-DBS in patients with Parkinson’s disease: A 10-year review of local experiences in Hong Kong

    V. Tang, X.L. Zhu, D. Chan, C. Lau, A. Chan, V. Mok, J. Yeung, W.S. Poon (Hong Kong)

    Objective: The purpose of the study was to determine the long-term neurocognitive outcomes of STN-DBS for PD. Background: Cognitive disturbances is one of the most…
  • 2018 International Congress

    Transcranial magnetic stimulation increases cognition globally and longitudinally in Parkinson’s disease

    J. Trung, A. Hanganu, S. Jobert, C. Degroot, B. Mejia-Constain, M.A. Bruneau, A.L. Lafontaine, Q.P.N. Clinicians, A. Strafella, O. Monchi (Montréal, QC, Canada)

    Objective: Using intermittent “theta burst” transcranial magnetic stimulation (iTBS) over the left dorsolateral prefrontal cortex (DLPFC) to assess the potential of long-term improvements in cognitive…
  • 2018 International Congress

    Sex Differences in Cognitive Performance in De-Novo Parkinson’s Disease

    S. Banks, E. Bayram, J. Kaylegian, B. Bluett (Las Vegas, NV, USA)

    Objective: To investigate whether sex affects cognition in patients with de-novo Parkinson’s disease (PD). Background: Sex differences in PD are common and may be due…
  • 2018 International Congress

    A bayesian network approach for prediction of future dementia in Parkinson’s disease

    P. Surathi, M. Mirian, K. Sundvick, S. Appel-Cresswell, M. McKeown (Vancouver, BC, Canada)

    Objective: To predict subsequent development of Parkinson’s dementia using parameters which can be easily obtained in a regular clinic visit using a machine learning approach.…
  • 2018 International Congress

    Rivastigmine solution in the one-year treatment of Parkinson’s disease dementia and dementia with Lewy bodies

    P.Y. Chiu (Changhua, Taiwan)

    Objective: Efficacy and safety of rivastigmine solution in the treatment of dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD) is not well studied…
  • 2018 International Congress

    Effect of Glucocerebrosidase enzymatic activity on neural activation during a cognitive task in Parkinson’s disease patients

    M. Ramezani, J.S. Provost, N. Auclair-Ouellet, I. Kathol, A. Hanganu, M. Kibreab, J. Cheetham, T. Hammer, L. Derwent, A. Robichaud, R. Chiang, J. Sarna, SP. Sardi, O. Monchi (Calgary, AB, Canada)

    Objective: To explore the potential correlation of blood Glucocerebrosidase (GCase) enzymatic activity with fMRI brain activity during Wisconsin Card Sorting Task (WCST), while assessing cognitive…
  • 2018 International Congress

    Curcumin improves cognitive function in rotenone-induced rat model of Parkinson’s disease (PD)

    S. Madiha, S. Haider (Karachi, Pakistan)

    Objective: In this study, we aimed to investigate the neuroprotective effect of curcumin against rotenone-induced memory impairments in rat PD model. Background: In PD, oxidative…
  • 2018 International Congress

    Cerebellar tDCS modulates negative emotions recognition in Parkinson’s disease

    F. Ruggiero, F. Cortese, M. Nigro, T. Bocci, L. Borellini, M. Vergari, F. Mameli, A. Priori, R. Ferrucci (Milano, Italy)

    Objective: To evaluate the role of the cerebellum in recognizing facial expressions in Parkinson's Disease (PD) patients. Background: PD is a neurodegenerative disorder characterized by…
  • « Previous Page
  • 1
  • …
  • 1133
  • 1134
  • 1135
  • 1136
  • 1137
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley